Cyclophosphamide promotes engraftment of gene-modified cells in a mouse model of Fanconi anemia without causing cytogenetic abnormalities

A major hurdle for hematopoietic stem cell (HSC) gene therapy for inherited bone marrow disorders, including Fanconi anemia (FA), is adequate engraftment of gene-modified cells. A phenotypic defect in DNA repair renders FA patients sensitive to alkylating agents such as cyclophosphamide (Cy); howeve...

Full description

Saved in:
Bibliographic Details
Main Authors: Adair, Jennifer E., Zhao, Xin, Chien, Sylvia, Fang, Min, Wohlfahrt, Martin E., Trobridge, Grant D., Taylor, Jason A., Beard, Brian C., Kiem, Hans-Peter, Becker, Pamela S.
Format: Artigo
Language:Inglês
Published: 2012
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3650894/
https://ncbi.nlm.nih.gov/pubmed/22660274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00109-012-0905-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items